NEW YORK, Dec. 22, 2014 /PRNewswire/ -- The North American Intrauterine Contraceptive Devices (IUCD) market is estimated to grow at a CAGR of 0.3% from 2014 to 2019. The growth of this market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception, fewer side effects of IUCDs, implementation of the Affordable Care Act (ACA), rising initiatives of private firms directed at reducing abortion-related expenses, funds/grants for IUCD products, and technological advancements.
Moreover, the rising number of players in this segment and technological advancements are creating growth opportunities for the North American intrauterine contraceptive devices market. However, high cost of treatment, threat of causing pelvic inflammatory infection (PID), threat of causing ectopic pregnancy, high rate of complications in unplanned pregnancies, and the need for compulsory assistance of a medical professional for the insertion of IUCDs is restraining the growth of the IUCD market in North America.
In this report, the North American intrauterine contraceptive devices market has been broadly classified on the basis of types, which include hormonal IUCDs and copper IUCDs. The hormonal IUCD market segment accounts for the largest market share of 83.4% of the North American IUCD market. Factors such as safety, easy removal, lighter periods, and the increasing adoption of hormonal IUD products such as Mirean and Skyla in the U.S. are driving the growth of this market.
Geographically, the U.S. is estimated to command the largest share of 93.1% of the North American IUCD market in 2014, followed by Canada. This market in the U.S. is primarily driven by the Affordable Care Act and technological advancements in the development of IUCDs. However, stringent regulatory and reimbursement policies in the U.S. and the threat of developing PID infections are restraining the growth of the IUCD market in this region.
The North American Intrauterine Contraceptive Devices market is a competitive market with a number of market players. As of 2014, this market is estimated to be dominated by Bayer HealthCare AG (a subsidiary of BAYER AG) (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Actavis plc (Ireland), and Medicines360 (Ireland). New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to grow within the IUCD market in North America.
Reasons to Buy the Report
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the North American IUCD market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both, established firms as well as new entrants/smaller firms, and will enable them to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or combination of the five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) mentioned below to strengthen their market share.
The report provides insights on the following:
- Market Penetration: Comprehensive information on IUCDs offered by top players in the North American IUCD market
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in this market
- Market Development: Comprehensive information about lucrative emerging markets; analysis of various IUCD markets across the North American region
- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the North America IUCD market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the IUCD market in North America
Read the full report: http://www.reportlinker.com/p02562541-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/north-american-intrauterine-contraceptive-devices-market-300012986.html
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article